ZLN005, a PGC-1α Activator, Protects the Liver against Ischemia–Reperfusion Injury and the Progression of Hepatic Metastases
Our study highlights the effective protection of ZLN005 pretreatment as a therapeutic alternative in terms of acute liver injury and tumor metastases.
Authors
- Taylor J. Austin
- Samer Tohme (ORCID: https://orcid.org/0000-0001-8770-9706)
- Hamza O. Yazdani (ORCID: https://orcid.org/0000-0002-3437-0339)
- David A. Geller (ORCID: https://orcid.org/0000-0003-0735-1068)
- Celine Tohme (ORCID: https://orcid.org/0009-0005-9450-0763)
- Patricia Loughran (ORCID: https://orcid.org/0000-0001-9375-1724)
- Tony Haykal (ORCID: https://orcid.org/0000-0002-0475-4833)
- Ruiqi Yang (ORCID: https://orcid.org/0000-0003-3188-2547)
- Richard L. Simmons (ORCID: https://orcid.org/0000-0001-6735-9913)
Institutions
- University of Pittsburgh (US)
- Tsinghua University (CN)
Publication Details
- Journal
- Cells
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3390/cells13171448
- Citations
- 9
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 2.10